|
US25386A
(en)
|
|
1859-09-13 |
|
Fastening fob |
|
US2833779A
(en)
|
1956-10-29 |
1958-05-06 |
American Cyanamid Co |
Substituted pyrazoles
|
|
US2918408A
(en)
|
1957-04-08 |
1959-12-22 |
Lakeside Lab Inc |
Anti-spasmodic compositions specific for treating spasm of the colon
|
|
US3910913A
(en)
|
1969-11-04 |
1975-10-07 |
American Home Prod |
4,5-Diamino-7H-pyrrolo{8 2,3-d{9 pyrimidine derivatives
|
|
US3631045A
(en)
|
1969-11-04 |
1971-12-28 |
American Home Prod |
4 5-diamino-7h-pyrrolo(2 3-d)pyrimidine derivatives
|
|
US3707475A
(en)
|
1970-11-16 |
1972-12-26 |
Pfizer |
Antiinflammatory imidazoles
|
|
US3940486A
(en)
|
1971-05-10 |
1976-02-24 |
Ciba-Geigy Corporation |
Imidazole derivatives in the treatment of pain
|
|
US3929807A
(en)
|
1971-05-10 |
1975-12-30 |
Ciba Geigy Corp |
2-Substituted-4(5)-(aryl)-5(4)-(2,3 or -4-pyridyl)-imidazoles
|
|
CA966134A
(en)
|
1972-05-05 |
1975-04-15 |
Haydn W.R. Williams |
1,8-naphthyridine compounds
|
|
US4058614A
(en)
|
1973-12-04 |
1977-11-15 |
Merck & Co., Inc. |
Substituted imidazole compounds and therapeutic compositions therewith
|
|
US4199592A
(en)
|
1978-08-29 |
1980-04-22 |
E. I. Du Pont De Nemours And Company |
Antiinflammatory 4,5-diaryl-2-nitroimidazoles
|
|
JPS5618982A
(en)
|
1979-06-14 |
1981-02-23 |
Wellcome Found |
Pyrimidine derivatives and medicinal drug containing them
|
|
GB2064336B
(en)
|
1979-12-06 |
1984-03-14 |
Glaxo Group Ltd |
Device for dispensing medicaments
|
|
DD201677A5
(de)
|
1980-07-25 |
1983-08-03 |
Ciba Geigy |
Verfahren zur herstellung von trisubstituierten imidazolderivaten
|
|
US4353656A
(en)
|
1980-10-14 |
1982-10-12 |
Xerox Corporation |
Moving coil, multiple energy print hammer system including a closed loop servo
|
|
DE3274065D1
(de)
|
1981-07-08 |
1986-12-11 |
Draco Ab |
Powder inhalator
|
|
WO1983002613A1
(fr)
|
1981-07-20 |
1983-08-04 |
Sallmann, Alfred |
Composes oxazoiques a triple substitution
|
|
US4503065A
(en)
|
1982-08-03 |
1985-03-05 |
E. I. Du Pont De Nemours And Company |
Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
|
|
GB2169265B
(en)
|
1982-10-08 |
1987-08-12 |
Glaxo Group Ltd |
Pack for medicament
|
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
|
ES286422Y
(es)
|
1982-10-08 |
1986-09-16 |
Glaxo Group Limited |
Dispositivo para administrar medicamentos a pacientes
|
|
JPS60226882A
(ja)
|
1984-04-24 |
1985-11-12 |
Nippon Zoki Pharmaceut Co Ltd |
新規ピリミドピリミジン誘導体
|
|
US4565875A
(en)
|
1984-06-27 |
1986-01-21 |
Fmc Corporation |
Imidazole plant growth regulators
|
|
US4560691A
(en)
|
1984-07-13 |
1985-12-24 |
Sterling Drug Inc. |
5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation
|
|
AT396872B
(de)
|
1985-07-30 |
1993-12-27 |
Glaxo Group Ltd |
Gerät zur verabreichung von medikamenten in pulverform
|
|
US4686231A
(en)
|
1985-12-12 |
1987-08-11 |
Smithkline Beckman Corporation |
Inhibition of 5-lipoxygenase products
|
|
IL83467A0
(en)
|
1986-08-15 |
1988-01-31 |
Fujisawa Pharmaceutical Co |
Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
|
|
AU598093B2
(en)
|
1987-02-07 |
1990-06-14 |
Wellcome Foundation Limited, The |
Pyridopyrimidines, methods for their preparation and pharmaceutical formulations thereof
|
|
JPH01261306A
(ja)
|
1988-04-13 |
1989-10-18 |
Nippon Kayaku Co Ltd |
２−アルキルチオ−４−アミノピリミジン誘導体を有効成分とする開花促進剤
|
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
BG94957A
(bg)
|
1990-08-10 |
1993-12-24 |
Ciba - Geigy Ag |
Пиримидинови производни и средство за борба срещу вредители по растенията
|
|
FR2665898B1
(fr)
|
1990-08-20 |
1994-03-11 |
Sanofi |
Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
|
IE913473A1
(en)
|
1990-10-15 |
1992-04-22 |
Fujisawa Pharmaceutical Co |
Quinazoline derivatives and their preparation
|
|
JPH06502178A
(ja)
|
1990-12-31 |
1994-03-10 |
藤沢薬品工業株式会社 |
イミダゾトリアジン誘導体
|
|
JP3375659B2
(ja)
|
1991-03-28 |
2003-02-10 |
テキサス インスツルメンツ インコーポレイテツド |
静電放電保護回路の形成方法
|
|
AU658646B2
(en)
|
1991-05-10 |
1995-04-27 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
FR2676734B1
(fr)
|
1991-05-23 |
1995-05-19 |
Roussel Uclaf |
Nouveaux derives de la pyrimidine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
|
|
IL102764A0
(en)
|
1991-08-16 |
1993-01-31 |
Merck & Co Inc |
Quinazoline derivatives,and pharmaceutical compositions containing them
|
|
DE4131029A1
(de)
*
|
1991-09-18 |
1993-07-29 |
Basf Ag |
Substituierte pyrido (2,3-d) pyrimidine als antidots
|
|
GB9127376D0
(en)
|
1991-12-24 |
1992-02-19 |
Wellcome Found |
Amidino derivatives
|
|
IL104369A0
(en)
|
1992-01-13 |
1993-05-13 |
Smithkline Beecham Corp |
Novel compounds and compositions
|
|
US5716972A
(en)
|
1993-01-13 |
1998-02-10 |
Smithkline Beecham Corporation |
Pyridyl substituted imidazoles
|
|
US6008235A
(en)
|
1992-01-13 |
1999-12-28 |
Smithkline Beecham Corporation |
Pyridyl substituted imidazoles
|
|
US5656644A
(en)
|
1994-07-20 |
1997-08-12 |
Smithkline Beecham Corporation |
Pyridyl imidazoles
|
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
|
MX9301943A
(es)
|
1992-04-02 |
1994-08-31 |
Smithkline Beecham Corp |
Compuestos.
|
|
GB9303993D0
(en)
|
1993-02-26 |
1993-04-14 |
Fujisawa Pharmaceutical Co |
New heterocyclic derivatives
|
|
US5466692A
(en)
|
1993-03-24 |
1995-11-14 |
American Home Products Corporation |
Substituted pyridopyrimidines and antihypertensives
|
|
US5593992A
(en)
|
1993-07-16 |
1997-01-14 |
Smithkline Beecham Corporation |
Compounds
|
|
US5670527A
(en)
|
1993-07-16 |
1997-09-23 |
Smithkline Beecham Corporation |
Pyridyl imidazole compounds and compositions
|
|
US5593991A
(en)
|
1993-07-16 |
1997-01-14 |
Adams; Jerry L. |
Imidazole compounds, use and process of making
|
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
|
EP0724588B1
(en)
|
1993-09-17 |
1999-11-10 |
Smithkline Beecham Corporation |
Drug binding protein
|
|
US5426110A
(en)
|
1993-10-06 |
1995-06-20 |
Eli Lilly And Company |
Pyrimidinyl-glutamic acid derivatives
|
|
DE69433501T2
(de)
|
1993-11-08 |
2004-11-04 |
Smithkline Beecham Corp. |
Oxazole zur behandlung von zytokinvermittelten erkrankungen
|
|
GB9325217D0
(en)
|
1993-12-09 |
1994-02-09 |
Zeneca Ltd |
Pyrimidine derivatives
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
|
US5547954A
(en)
*
|
1994-05-26 |
1996-08-20 |
Fmc Corporation |
2,4-Diamino-5,6-disubstituted-and 5,6,7-trisubstituted-5-deazapteridines as insecticides
|
|
US5545669A
(en)
|
1994-06-02 |
1996-08-13 |
Adams; Jerry L. |
Anti-inflammatory compounds
|
|
TW574214B
(en)
|
1994-06-08 |
2004-02-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
EP0957087B1
(en)
|
1994-06-15 |
2002-12-04 |
The Wellcome Foundation Limited |
Intermediates useful in the preparation of enzyme inhibitors
|
|
US5998428A
(en)
|
1995-05-31 |
1999-12-07 |
Smithkline Beecham Corporation |
Compounds and methods for treating PDE IV-related diseases
|
|
CN1043993C
(zh)
|
1994-08-29 |
1999-07-07 |
山之内制药株式会社 |
萘啶衍生物及其医药组合物
|
|
IL115256A0
(en)
|
1994-11-14 |
1995-12-31 |
Warner Lambert Co |
6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
|
|
KR19980702911A
(ko)
|
1995-03-10 |
1998-09-05 |
테릴 케이. 퀄리 |
에어로졸 밸브
|
|
US5620981A
(en)
*
|
1995-05-03 |
1997-04-15 |
Warner-Lambert Company |
Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
|
|
US5760220A
(en)
|
1995-06-07 |
1998-06-02 |
American Home Products Corporation |
Process for preparation of biphenyl derivatives
|
|
US5739143A
(en)
|
1995-06-07 |
1998-04-14 |
Smithkline Beecham Corporation |
Imidazole compounds and compositions
|
|
CA2223783A1
(en)
|
1995-06-07 |
1996-12-19 |
Michel Bernatchez |
Process for preparation of biphenyl derivatives
|
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
|
ZA9610687B
(en)
|
1995-12-22 |
1997-09-29 |
Smithkline Beecham Corp |
Novel synthesis.
|
|
ZA97175B
(en)
|
1996-01-11 |
1997-11-04 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds.
|
|
US5977103A
(en)
|
1996-01-11 |
1999-11-02 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
US6150337A
(en)
|
1996-01-23 |
2000-11-21 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
|
|
US5767097A
(en)
*
|
1996-01-23 |
1998-06-16 |
Icn Pharmaceuticals, Inc. |
Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
|
|
US20020137696A1
(en)
|
1996-01-23 |
2002-09-26 |
Robert Tam |
Specific modulation of TH1/TH2 cytokine expression by ribavirin in activated T-lymphocytes
|
|
JP2000507224A
(ja)
|
1996-03-08 |
2000-06-13 |
スミスクライン・ビーチャム・コーポレイション |
Ｃｓａｉｄ化合物の血管形成の抑制物質としての使用
|
|
JP2000507558A
(ja)
|
1996-03-25 |
2000-06-20 |
スミスクライン・ビーチャム・コーポレイション |
Ｃｎｓ損傷についての新規な治療
|
|
JP2000507545A
(ja)
|
1996-03-25 |
2000-06-20 |
スミスクライン・ビーチャム・コーポレイション |
Ｃｎｓ損傷についての新規な治療
|
|
AU2521597A
(en)
|
1996-04-12 |
1997-11-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyramidine derivatives
|
|
US6875769B2
(en)
|
1996-05-23 |
2005-04-05 |
Pfizer Inc. |
Substituted6,6-hetero-bicyclicderivatives
|
|
ZA973884B
(en)
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
|
WO1998005661A1
(en)
|
1996-08-06 |
1998-02-12 |
Pfizer Inc. |
Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
|
|
TW477787B
(en)
|
1996-08-27 |
2002-03-01 |
Pfizer |
Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
|
|
US6455690B1
(en)
|
1996-10-16 |
2002-09-24 |
Robert Tam |
L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
|
|
US6509320B1
(en)
|
1996-10-16 |
2003-01-21 |
Icn Pharmaceuticals, Inc. |
Purine L-nucleosides, analogs and uses thereof
|
|
CA2266889A1
(en)
|
1996-10-16 |
1998-04-23 |
Guangyi Wang |
Purine l-nucleosides, analogs and uses thereof
|
|
US6147080A
(en)
|
1996-12-18 |
2000-11-14 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
GB9700226D0
(en)
|
1997-01-08 |
1997-02-26 |
Glaxo Group Ltd |
Inhalation device
|
|
US5929076A
(en)
|
1997-01-10 |
1999-07-27 |
Smithkline Beecham Corporation |
Cycloalkyl substituted imidazoles
|
|
MY117948A
(en)
|
1997-01-13 |
2004-08-30 |
Glaxo Group Ltd |
Nitride oxide synthase inhibitors.
|
|
US6268310B1
(en)
|
1997-01-28 |
2001-07-31 |
Nippon Soda Co., Ltd. |
Oxazole derivative, process for producing the same, and herbicide
|
|
US5945422A
(en)
|
1997-02-05 |
1999-08-31 |
Warner-Lambert Company |
N-oxides of amino containing pyrido 2,3-D! pyrimidines
|
|
US6498163B1
(en)
|
1997-02-05 |
2002-12-24 |
Warner-Lambert Company |
Pyrido[2,3-D]pyrimidines and 4-aminopyrimidines as inhibitors of cellular proliferation
|
|
ES2301194T3
(es)
|
1997-02-05 |
2008-06-16 |
Warner-Lambert Company Llc |
Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
|
|
DE19723722A1
(de)
|
1997-05-30 |
1998-12-10 |
Schering Ag |
Nichtsteroidale Gestagene
|
|
AU9281298A
(en)
|
1997-10-01 |
1999-04-23 |
Kyowa Hakko Kogyo Co. Ltd. |
Benzodioxole derivatives
|
|
WO1999017776A1
(en)
|
1997-10-08 |
1999-04-15 |
Smithkline Beecham Corporation |
Novel cycloalkenyl substituted compounds
|
|
US6335340B1
(en)
|
1997-12-19 |
2002-01-01 |
Smithkline Beecham Corporation |
compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses
|
|
US6423695B1
(en)
|
1998-01-13 |
2002-07-23 |
Ribapharm, Inc. |
Cytokine related treatments of disease
|
|
US6506766B1
(en)
|
1998-02-13 |
2003-01-14 |
Abbott Laboratories |
Glucocortiocoid-selective antinflammatory agents
|
|
CA2321153A1
(en)
|
1998-02-17 |
1999-08-19 |
Timothy D. Cushing |
Anti-viral pyrimidine derivatives
|
|
US6306866B1
(en)
|
1998-03-06 |
2001-10-23 |
American Cyanamid Company |
Use of aryl-substituted pyrimidines as insecticidal and acaricidal agents
|
|
CA2323771A1
(en)
|
1998-03-14 |
1999-09-23 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Phthalazinone pde iii/iv inhibitors
|
|
JP2000038350A
(ja)
|
1998-05-18 |
2000-02-08 |
Yoshitomi Pharmaceut Ind Ltd |
糖尿病治療薬
|
|
US6248225B1
(en)
|
1998-05-26 |
2001-06-19 |
Ppg Industries Ohio, Inc. |
Process for forming a two-coat electrodeposited composite coating the composite coating and chip resistant electrodeposited coating composition
|
|
US20040044012A1
(en)
|
1998-05-26 |
2004-03-04 |
Dobrusin Ellen Myra |
Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
|
|
ES2310039T3
(es)
|
1998-05-26 |
2008-12-16 |
Warner-Lambert Company Llc |
Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular.
|
|
US6423425B1
(en)
|
1998-05-26 |
2002-07-23 |
Ppg Industries Ohio, Inc. |
Article having a chip-resistant electrodeposited coating and a process for forming an electrodeposited coating
|
|
GB9811599D0
(en)
|
1998-05-30 |
1998-07-29 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
AU4429799A
(en)
|
1998-06-12 |
1999-12-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
US5907465A
(en)
|
1998-08-13 |
1999-05-25 |
Sensormatic Electronics Corporation |
Circuit for energizing EAS marker deactivation device with DC pulses of alternating polarity
|
|
US6184226B1
(en)
*
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
CA2337755C
(en)
|
1998-09-18 |
2008-07-29 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
BR9914162A
(pt)
*
|
1998-10-01 |
2001-06-26 |
Astrazeneca Ab |
Derivado de amida, processo para preparar um derivado de amida, ou um sal farmaceuticamente aceitável ou éster clivável in vivo do mesmo, composição farmacêutica e uso de um derivado de amida, ou um sal farmaceuticamente aceitável ou éster clivável in vivo do mesmo
|
|
WO2000023444A1
(en)
|
1998-10-21 |
2000-04-27 |
Abbott Laboratories |
5,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds
|
|
WO2000024744A1
(en)
|
1998-10-23 |
2000-05-04 |
F. Hoffmann-La Roche Ag |
Bicyclic nitrogen heterocycles
|
|
US6358959B1
(en)
|
1999-01-26 |
2002-03-19 |
Merck & Co., Inc. |
Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists
|
|
AR035987A1
(es)
|
1999-03-01 |
2004-08-04 |
Smithkline Beecham Corp |
Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio
|
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
EP1175422A2
(en)
|
1999-05-04 |
2002-01-30 |
Ligand Pharmaceuticals Incorporated |
Tetracyclic progesterone receptor modulator compounds and methods
|
|
EP1196167B1
(en)
*
|
1999-07-02 |
2006-04-19 |
Stuart A. Lipton |
Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
US6263209B1
(en)
|
1999-07-28 |
2001-07-17 |
Motorola, Inc. |
Method and apparatus in a wireless communication system for creating a learning function
|
|
CZ302882B6
(cs)
|
1999-08-21 |
2012-01-04 |
Nycomed Gmbh |
Farmaceutický prostredek
|
|
CO5180649A1
(es)
|
1999-09-01 |
2002-07-30 |
Abbott Lab |
Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
|
|
WO2001019322A2
(en)
|
1999-09-17 |
2001-03-22 |
Smithkline Beecham Corporation |
Use of csaids in rhinovirus infection
|
|
SK3792002A3
(en)
|
1999-09-17 |
2003-09-11 |
Abbott Gmbh & Co Kg |
Kinase inhibitors as therapeutic agents
|
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
|
WO2001042243A2
(en)
|
1999-12-08 |
2001-06-14 |
Advanced Medicine, Inc. |
Protein kinase inhibitors
|
|
US6632666B2
(en)
|
2000-01-14 |
2003-10-14 |
Biolife Solutions, Inc. |
Normothermic, hypothermic and cryopreservation maintenance and storage of cells, tissues and organs in gel-based media
|
|
ES2487897T3
(es)
|
2000-01-21 |
2014-08-25 |
Novartis Ag |
Combinaciones que consisten de inhibidores de la dipeptidilpeptidasa-IV y agentes antidiabéticos
|
|
MXPA02007221A
(es)
|
2000-01-25 |
2002-11-29 |
Warner Lambert Co |
Inhibidores de pirido [2,3-d)pirimidin-2,7-diamina cinasa.
|
|
PL357634A1
(en)
|
2000-01-27 |
2004-07-26 |
Warner-Lambert Company |
Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
|
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
|
SK12472002A3
(sk)
|
2000-03-06 |
2003-04-01 |
Warner-Lambert Company |
5-Alkylpyrido[2,3-d]pyrimidínové inhibítory tyrosínových kináz
|
|
CA2423251A1
(en)
|
2000-09-29 |
2002-04-04 |
Glaxo Group Limited |
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
|
|
JP2004530648A
(ja)
|
2000-10-19 |
2004-10-07 |
スミスクライン・ビーチャム・コーポレイション |
炎症により促進される咳の治療のためのｐ３８阻害剤の使用
|
|
IL155367A0
(en)
|
2000-10-23 |
2003-12-23 |
Smithkline Beecham Corp |
NOVEL 2,4,8-TRISUBSTITUTED-8h-PYRIDO[2,3,-d]PYRIMIDIN-7-ONE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, PROCESSES FOR THE PREPARATION THEREOF, AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR TREATING CSBP/p38 KINASE MEDIATED DISEASES
|
|
JP2002205986A
(ja)
|
2000-11-08 |
2002-07-23 |
Takeda Chem Ind Ltd |
ピリミジン誘導体およびそれを含有する除草剤
|
|
US6945422B2
(en)
*
|
2000-11-08 |
2005-09-20 |
Delphi Technologies, Inc. |
In-tank fuel line quick connector assembly
|
|
WO2002058695A1
(en)
|
2000-12-20 |
2002-08-01 |
Merck & Co., Inc. |
(halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
|
|
GB0031179D0
(en)
|
2000-12-21 |
2001-01-31 |
Glaxo Group Ltd |
Nitric oxide synthase inhibitors
|
|
US6484903B2
(en)
|
2001-01-09 |
2002-11-26 |
Riverwood International Corporation |
Carton with an improved dispensing feature in combination with a unique handle
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
WO2002064096A2
(en)
|
2001-02-16 |
2002-08-22 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
|
DE10108481A1
(de)
|
2001-02-22 |
2002-10-24 |
Bayer Ag |
Pyridylpyrimidine
|
|
US7144908B2
(en)
|
2001-03-08 |
2006-12-05 |
Glaxo Group Limited |
Agonists of beta-adrenoceptors
|
|
US7045658B2
(en)
|
2001-03-22 |
2006-05-16 |
Glaxo Group Limited |
Formailide derivatives as beta2-adrenoreceptor agonists
|
|
WO2002088079A2
(en)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Dual inhibitors of pde 7 and pde 4
|
|
US7105667B2
(en)
|
2001-05-01 |
2006-09-12 |
Bristol-Myers Squibb Co. |
Fused heterocyclic compounds and use thereof
|
|
HUP0402352A2
(hu)
|
2001-06-19 |
2005-02-28 |
Bristol-Myers Squibb Co. |
Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
|
|
PE20030008A1
(es)
|
2001-06-19 |
2003-01-22 |
Bristol Myers Squibb Co |
Inhibidores duales de pde 7 y pde 4
|
|
BRPI0212455B8
(pt)
|
2001-09-14 |
2021-05-25 |
Glaxo Group Ltd |
composto derivado de fenetanolamina para o tratamento de doenças respiratórias, formulação farmacêutica, combinação, e, uso do mesmo
|
|
GB0124941D0
(en)
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP4178783B2
(ja)
|
2001-10-19 |
2008-11-12 |
三菱化学株式会社 |
光学記録媒体
|
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
|
US7019002B2
(en)
|
2001-12-11 |
2006-03-28 |
Pharmacia & Upjohn, S.P.A. |
Pyridopyrimidinones derivatives as telomerase inhibitors
|
|
CA2472746A1
(en)
|
2002-01-14 |
2003-07-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
|
JP4291696B2
(ja)
*
|
2002-01-22 |
2009-07-08 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
２−（ピリジン−２−イルアミノ）−ピリド［２，３−ｄ］ピリミジン−７−オン
|
|
EP1467730A4
(en)
|
2002-01-22 |
2010-03-10 |
Univ California |
Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof
|
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
|
JP2005521717A
(ja)
|
2002-03-26 |
2005-07-21 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
DE60318188T2
(de)
|
2002-03-26 |
2008-12-11 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
|
|
DE10215316C1
(de)
|
2002-04-02 |
2003-12-18 |
Schering Ag |
Chinolin- und Isochinolin-Derivate, ein pharmazeutisches Mittel und ihre Verwendung als Entzündungshemmer
|
|
WO2003086294A2
(en)
|
2002-04-11 |
2003-10-23 |
Merck & Co., Inc. |
1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
|
|
WO2003091204A1
(en)
|
2002-04-25 |
2003-11-06 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
|
AU2003232071A1
(en)
|
2002-05-06 |
2003-11-17 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
|
ITBO20020304A1
(it)
|
2002-05-17 |
2003-11-17 |
Magneti Marelli Powertrain Spa |
Nuovi condotti in materiale polimerico
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
AR040456A1
(es)
*
|
2002-06-27 |
2005-04-06 |
Bristol Myers Squibb Co |
Piridina n-oxidos 2,4 -disubstituidos utiles como inhibidores de transcriptasa inversa del virus de inmunodeficiencia humana
|
|
EP1521733B1
(en)
|
2002-07-08 |
2014-08-20 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
EP1575502B1
(en)
|
2002-07-18 |
2010-01-20 |
Bristol-Myers Squibb Company |
Compositions and methods involving nuclear hormone receptor site ii
|
|
JP2006508042A
(ja)
|
2002-07-18 |
2006-03-09 |
ブリストル−マイヤーズ スクイブ カンパニー |
グルココルチコイド受容体の修飾物質および方法
|
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
WO2004018429A2
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
|
CA2499150A1
(en)
|
2002-09-20 |
2004-04-01 |
Merck & Co., Inc. |
Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators
|
|
WO2004037807A2
(en)
|
2002-10-22 |
2004-05-06 |
Glaxo Group Limited |
Medicinal arylethanolamine compounds
|
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
|
RU2332400C2
(ru)
|
2002-10-28 |
2008-08-27 |
Глаксо Груп Лимитед |
Производные фенэтаноламина для лечения респираторных заболеваний
|
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
|
TW200413381A
(en)
*
|
2002-11-04 |
2004-08-01 |
Hoffmann La Roche |
Novel amino-substituted dihydropyrimido [4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
|
|
AU2003291310A1
(en)
|
2002-11-06 |
2004-06-03 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds and use thereof
|
|
JP2004203751A
(ja)
|
2002-12-24 |
2004-07-22 |
Pfizer Inc |
置換６，６−ヘテロ二環式誘導体
|
|
WO2004065378A1
(en)
|
2003-01-17 |
2004-08-05 |
Warner-Lambert Company Llc |
2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation
|
|
JP2006517976A
(ja)
|
2003-02-14 |
2006-08-03 |
スミスクライン・ビーチャム・コーポレイション |
新規化合物
|
|
US7138412B2
(en)
|
2003-03-11 |
2006-11-21 |
Bristol-Myers Squibb Company |
Tetrahydroquinoline derivatives useful as serine protease inhibitors
|
|
WO2004106308A1
(en)
|
2003-05-27 |
2004-12-09 |
Pfizer Products Inc. |
Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
|
|
AR045445A1
(es)
|
2003-08-05 |
2005-10-26 |
Vertex Pharma |
Compuestos ihinibidores de canales ionicos regulados por voltaje
|
|
DE102004020908A1
(de)
|
2004-04-28 |
2005-11-17 |
Grünenthal GmbH |
Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen
|
|
US7098222B2
(en)
|
2004-05-12 |
2006-08-29 |
Abbott Laboratories |
Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
|
|
PE20100741A1
(es)
|
2005-03-25 |
2010-11-25 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
|
|
JP2008535822A
(ja)
|
2005-03-25 |
2008-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
|
JP2008537937A
(ja)
|
2005-03-25 |
2008-10-02 |
グラクソ グループ リミテッド |
ピリド［２，３−ｄ］ピリミジン−７−オンおよび３，４−ジヒドロピリミド［４，５−ｄ］ピリミジン−２（１Ｈ）−オン誘導体の製造方法
|
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
WO2006127678A2
(en)
|
2005-05-23 |
2006-11-30 |
Smithkline Beecham Corporation |
Inhibition of p38 mark for treatment of obesity
|
|
EP1931667A1
(en)
*
|
2005-09-28 |
2008-06-18 |
Ranbaxy Laboratories Limited |
Pyrido-pyridimidine derivatives useful as antiinflammatory agents
|
|
EP1940839B1
(en)
*
|
2005-10-07 |
2013-07-31 |
Exelixis, Inc. |
PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kalpha
|
|
TW200738243A
(en)
*
|
2005-11-15 |
2007-10-16 |
Glaxo Group Ltd |
Novel process and formulations
|
|
US20090170834A1
(en)
*
|
2005-12-22 |
2009-07-02 |
Prolexys Pharmaceuticals, Inc. |
Fused Pyrimidones and Thiopyrimidones, and Uses Thereof
|
|
TW200800997A
(en)
*
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
ATE549334T1
(de)
*
|
2006-11-20 |
2012-03-15 |
Bristol Myers Squibb Co |
7,8-dihydro-1,6-naphthyridin-5(6h)-one und verwandte bicyclische verbindungen als hemmer der dipeptidyl-peptidase iv sowie verfahren
|
|
WO2009132980A1
(en)
*
|
2008-04-29 |
2009-11-05 |
F. Hoffmann-La Roche Ag |
Pyrimidinyl pyridone inhibitors of jnk.
|